Tissue Regenix Group (FRA:LSW) Change In Inventory: €-3.67 Mil (TTM As of Jun. 2025)


FRA:LSW Tissue Regenix Group PLC FRA:LSW
10 GF Score
Price €0.07
GF Value €0.84
! 5 Warning Signs
View Full Analysis

What is Tissue Regenix Group Change In Inventory?

Tissue Regenix Group FRA:LSW 10 Change In Inventory is €-3.67 Mil as of Jun. 2025. GuruFocus rates FRA:LSW with a GF Score™ of 10/100 and a GF Value™ of €0.84. The stock has 5 warning signs investors should review.

Tissue Regenix Group's change in inventory for the quarter that ended in Jun. 2025 was €-2.25 Mil. It means Tissue Regenix Group's inventory increased by €2.25 Mil from Dec. 2024 to Jun. 2025 .

Tissue Regenix Group's change in inventory for the fiscal year that ended in Dec. 2024 was €-3.67 Mil. It means Tissue Regenix Group's inventory increased by €3.67 Mil from Dec. 2023 to Dec. 2024 .

Tissue Regenix Group's Total Inventories for the quarter that ended in Jun. 2025 was €14.48 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Tissue Regenix Group's Days Inventory for the quarter that ended in Jun. 2025 was 365.25.

Inventory Turnover measures how fast the company turns over its inventory within a year. Tissue Regenix Group's Inventory Turnover for the quarter that ended in Jun. 2025 was 0.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Tissue Regenix Group's Inventory-to-Revenue for the quarter that ended in Jun. 2025 was 1.16.

Tissue Regenix Group  (FRA:LSW) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Tissue Regenix Group's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=13.9255/6.958*365 / 2
=365.25

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Tissue Regenix Group's Inventory Turnover for the quarter that ended in Jun. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=6.958 / 13.9255
=0.50

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Tissue Regenix Group's Inventory to Revenue for the quarter that ended in Jun. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=13.9255 / 11.961
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group Change In Inventory Related Terms

Tissue Regenix Group Change In Inventory Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group Change In Inventory Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.38 -0.10 -1.10 0.48 -3.67

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 0.92 -2.19 -1.42 -2.25
FRA:LSW
10GF Score
Tissue Regenix Group PLC FRA:LSW
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tissue Regenix Group Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-3.67 Mil mean?
Tissue Regenix Group (FRA:LSW) has a Change In Inventory of €-3.67 Mil as of Jun. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Tissue Regenix Group and its competitors.
Is Tissue Regenix Group's Change In Inventory too high?
Tissue Regenix Group's current Change In Inventory is €-3.67 Mil. Overall, Tissue Regenix Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Tissue Regenix Group's Change In Inventory compare to VRTX and REGN?
Tissue Regenix Group's Change In Inventory of €-3.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Tissue Regenix Group and its competitors. Tissue Regenix Group's current Change In Inventory is €-3.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (FRA:LSW) has a current Change In Inventory of €-3.67 Mil. The stock's GF Value™ is €0.84, compared to a current price of €0.07 — trading 91.7% below its estimated fair value. The current Change In Inventory is €-3.67 Mil. Tissue Regenix Group's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Tissue Regenix Group (FRA:LSW), the current Change In Inventory is €-3.67 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tissue Regenix Group (FRA:LSW) Overvalued in 2026?

Based on GuruFocus' analysis, Tissue Regenix Group stock appears to be undervalued. The current stock price of €0.07 is trading 91.7% below its estimated GF Value™ of €0.84.

Key valuation signals for FRA:LSW:

  • Change In Inventory: €-3.67 Mil
  • GF Value™: €0.84 vs. price of €0.07 (91.7% below fair value)
  • GF Score™: 10/100 with 5 warning signs

No single metric tells the full story. See the FRA:LSW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
10GF Score

Get the complete analysis for FRA:LSW

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.84
GF Value